Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$56,796,911
+$13,944,141 QoQ
Shares Held
1,043,869
+4.5% QoQ
Ownership
0.421%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 56%
None 44%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. EXEL ranks #17 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,796,911 | 1,043,869 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $42,852,770 | 999,132 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $35,705,846 | 814,644 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $27,249,944 | 659,805 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $31,847,799 | 722,500 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $17,105,441 | 463,311 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $31,091,377 | 933,675 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $41,286,188 | 1,590,990 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $33,920,171 | 1,509,576 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $44,913,129 | 1,892,673 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $44,598,031 | 1,859,026 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $49,532,464 | 2,266,932 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $39,140,624 | 2,048,175 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $44,299,908 | 2,282,324 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $38,780,228 | 2,417,720 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $39,076,205 | 2,492,105 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $39,250,613 | 1,885,236 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $52,956,619 | 2,335,978 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $36,295,688 | 1,985,541 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,340,926 | 489,164 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $12,854,427 | 705,512 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $16,082,655 | 711,937 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $15,932,327 | 793,838 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $17,727,275 | 725,042 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $22,169,787 | 933,858 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $13,340,126 | 774,688 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||